{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:24:28Z","timestamp":1790954668880,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,17]]},"DOI":"10.7759\/cureus.97120","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:43:38Z","timestamp":1763448218000},"source":"Crossref","is-referenced-by-count":3,"title":["Epidemiology and Antifungal Susceptibility of Candida Bloodstream Isolates From a Tertiary Care Center in Central India"],"prefix":"10.7759","author":[{"given":"Arati  A","family":"Bhadade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadepalli","family":"Karuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Panthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Beniwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand  K","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. R","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apoorva","family":"Devgade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Khadanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S378629","article-title":"Systematic characterization of epidemiology, antifungal susceptibility, risk factors and outcomes of Candidaemia: a six-year Chinese study","volume":"15","author":"Ye N","year":"2022","unstructured":"Ye N, Liu Z, Tang W, Li X, Chu W, Zhou Q. Systematic characterization of epidemiology, antifungal susceptibility, risk factors and outcomes of Candidaemia: a six-year Chinese study. Infect Drug Resist. 2022, 15:4887-98. 10.2147\/IDR.S378629","journal-title":"Infect Drug Resist"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1086\/502581","article-title":"Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance","volume":"26","author":"Morgan J","year":"2005","unstructured":"Morgan J, Meltzer MI, Plikaytis BD, et al.. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol. 2005, 26:540-7. 10.1086\/502581","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa193","article-title":"Burden of Candidemia in the United States, 2017","volume":"71","author":"Tsay SV","year":"2020","unstructured":"Tsay SV, Mu Y, Williams S, et al.. Burden of Candidemia in the United States, 2017. Clin Infect Dis. 2020, 71:e449-53. 10.1093\/cid\/ciaa193","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/cjhr.cjhr_12_20","article-title":"Candidemia - Changing trends from Candida albicans to non-albicans Candida from a tertiary care center in western UP, India","volume":"7","author":"Ahmed S","year":"2020","unstructured":"Ahmed S, Shahid M, Fatima N, Khan F, Tayyaba U. Candidemia - Changing trends from Candida albicans to non-albicans Candida from a tertiary care center in western UP, India. CHRISMED J Health Res. 2020, 7:167. 10.4103\/cjhr.cjhr_12_20","journal-title":"CHRISMED J Health Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/ijmm.IJMM_20_112","article-title":"Candidaemia in a tertiary care centre of developing country: Monitoring possible change in spectrum of agents and antifungal susceptibility","volume":"38","author":"Kaur H","year":"2020","unstructured":"Kaur H, Singh S, Rudramurthy SM, et al.. Candidaemia in a tertiary care centre of developing country: Monitoring possible change in spectrum of agents and antifungal susceptibility. Indian J Med Microbiol. 2020, 38:110-6. 10.4103\/ijmm.IJMM_20_112","journal-title":"Indian J Med Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13278","article-title":"Candidaemia in Central Slovenia: a 12-year retrospective survey","volume":"64","author":"Matos T","year":"2021","unstructured":"Matos T, Lejko Zupanc T, Skofljanec A, et al.. Candidaemia in Central Slovenia: a 12-year retrospective survey. Mycoses. 2021, 64:753-62. 10.1111\/myc.13278","journal-title":"Mycoses"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtumed.2020.12.002","article-title":"A seven-year surveillance of Candida bloodstream infection at a university hospital in KSA","volume":"16","author":"Al-Musawi TS","year":"2021","unstructured":"Al-Musawi TS, Alkhalifa WA, Alasaker NA, Rahman JU, Alnimr AM. A seven-year surveillance of Candida bloodstream infection at a university hospital in KSA. J Taibah Univ Med Sci. 2021, 16:184-90. 10.1016\/j.jtumed.2020.12.002","journal-title":"J Taibah Univ Med Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2019.05.017","article-title":"Poor prognosis of Candida tropicalis among non-albicans candidemia: a retrospective multicenter cohort study, Korea","volume":"95","author":"Ko JH","year":"2019","unstructured":"Ko JH, Jung DS, Lee JY, et al.. Poor prognosis of Candida tropicalis among non-albicans candidemia: a retrospective multicenter cohort study, Korea. Diagn Microbiol Infect Dis. 2019, 95:195-200. 10.1016\/j.diagmicrobio.2019.05.017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.759408","article-title":"Drug resistance and novel therapeutic approaches in invasive candidiasis","volume":"11","author":"Murphy SE","year":"2021","unstructured":"Murphy SE, Bicanic T. Drug resistance and novel therapeutic approaches in invasive candidiasis. Front Cell Infect Microbiol. 2021, 11:759408. 10.3389\/fcimb.2021.759408","journal-title":"Front Cell Infect Microbiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.8(11).4891-98","article-title":"Comparison of incidence, risk factors, outcome and antifungal susceptibility between Candida albicans and non-albicans Candida species in patients with candidemia in intensive care setting","volume":"8","author":"Tejan N","year":"2017","unstructured":"Tejan N, Singla N, Guglani V, Gombar S, Chander J. Comparison of incidence, risk factors, outcome and antifungal susceptibility between Candida albicans and non-albicans Candida species in patients with candidemia in intensive care setting. Int J Pharm Sci Res. 2017, 8:4891-8. 10.13040\/IJPSR.0975-8232.8(11).4891-98","journal-title":"Int J Pharm Sci Res"},{"key":"ref11","article-title":"Candida auris","author":"Sikora A","year":"2025","unstructured":"Sikora A, Zahra F. Candida auris. StatPearls, Treasure Island, FL; 2025."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.01995","article-title":"Genetic drivers of multidrug resistance in Candida glabrata","volume":"7","author":"Healey KR","year":"2016","unstructured":"Healey KR, Jimenez Ortigosa C, Shor E, Perlin DS. Genetic drivers of multidrug resistance in Candida glabrata. Front Microbiol. 2016, 7:1995. 10.3389\/fmicb.2016.01995","journal-title":"Front Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart SR","year":"2017","unstructured":"Lockhart SR, Etienne KA, Vallabhaneni S, et al.. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017, 64:134-40. 10.1093\/cid\/ciw691","journal-title":"Clin Infect Dis"},{"key":"ref14","unstructured":"Centers for Disease Control and Prevention. Antifungal susceptibility testing for Candida auris. (2024). Accessed. November 11, 2025: https:\/\/www.cdc.gov\/candida-auris\/hcp\/laboratories\/antifungal-susceptibility-testing.html."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.3.591-595.1999","article-title":"Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms","volume":"37","author":"Espinel-Ingroff A","year":"1999","unstructured":"Espinel-Ingroff A, Pfaller M, Messer SA, Knapp CC, Killian S, Norris HA, Ghannoum MA. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms. J Clin Microbiol. 1999, 37:591-5. 10.1128\/JCM.37.3.591-595.1999","journal-title":"J Clin Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-019-0539-2","article-title":"Candidemia in critically ill immunocompromised patients: report of a retrospective multicenter cohort study","volume":"9","author":"Ghrenassia E","year":"2019","unstructured":"Ghrenassia E, Mokart D, Mayaux J, et al.. Candidemia in critically ill immunocompromised patients: report of a retrospective multicenter cohort study. Ann Intensive Care. 2019, 9:62. 10.1186\/s13613-019-0539-2","journal-title":"Ann Intensive Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijmmtd.2024.040","article-title":"Candidemia in a tertiary care hospital: changing trends","volume":"10","author":"Babu A","year":"2024","unstructured":"Babu A, Kshirsagar D, Thakar VH, Dalal BA, Modak M, Kumar M. Candidemia in a tertiary care hospital: changing trends. IP Int J Med Microbiol Trop Diseases. 2024, 10:230-5. 10.18231\/j.ijmmtd.2024.040","journal-title":"IP Int J Med Microbiol Trop Diseases"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.21276\/APALM.2017.1000","article-title":"Candidemia profile and antifungal drugs susceptibility pattern in neonatal intensive care unit patients in a tertiary care teaching institute in Maharashtra","volume":"4","author":"Kulkarni VA","year":"2017","unstructured":"Kulkarni VA, Bhadade AA, Putta SD. Candidemia profile and antifungal drugs susceptibility pattern in neonatal intensive care unit patients in a tertiary care teaching institute in Maharashtra. Ann Pathol Lab Med. 2017, 4:113-8. 10.21276\/APALM.2017.1000","journal-title":"Ann Pathol Lab Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-020-00798-3","article-title":"A seven-year surveillance study of the epidemiology, antifungal susceptibility, risk factors and mortality of candidaemia among paediatric and adult inpatients in a tertiary teaching hospital in China","volume":"9","author":"Zeng Z","year":"2020","unstructured":"Zeng Z, Ding Y, Tian G, Yang K, Deng J, Li G, Liu J. A seven-year surveillance study of the epidemiology, antifungal susceptibility, risk factors and mortality of candidaemia among paediatric and adult inpatients in a tertiary teaching hospital in China. Antimicrob Resist Infect Control. 2020, 9:133. 10.1186\/s13756-020-00798-3","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/jgid.jgid_44_22","article-title":"Identification and antifungal drug susceptibility pattern of Candida auris in India","volume":"14","author":"Deshkar S","year":"2022","unstructured":"Deshkar S, Patil N, Amberkar S, Lad A, Siddiqui F, Sharan S. Identification and antifungal drug susceptibility pattern of Candida auris in India. J Glob Infect Dis. 2022, 14:131-5. 10.4103\/jgid.jgid_44_22","journal-title":"J Glob Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/20499361241263733","article-title":"Spectrum and management of rare Candida\/yeast infections in Kuwait in the Middle East","volume":"11","author":"Ahmad S","year":"2024","unstructured":"Ahmad S, Asadzadeh M, Al-Sweih N, Khan Z. Spectrum and management of rare Candida\/yeast infections in Kuwait in the Middle East. Ther Adv Infect Dis. 2024, 11:20499361241263733. 10.1177\/20499361241263733","journal-title":"Ther Adv Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.22034\/cmm.2024.345218.1529","article-title":"Candida utilis as an emerging rare cause of septicemia among neonates and children in Western Uttar Pradesh: a case series","volume":"10","author":"Singh DP","year":"2024","unstructured":"Singh DP, Verma RK, Yadav RK, Anant K, Das A. Candida utilis as an emerging rare cause of septicemia among neonates and children in Western Uttar Pradesh: a case series. Curr Med Mycol. 2024, 10:e2024.345184.1529. 10.22034\/cmm.2024.345218.1529","journal-title":"Curr Med Mycol"},{"key":"ref23","article-title":"Antifungal susceptibility profile and biofilm-producing capability of Candida tropicalis isolates in a tertiary medical centre","volume":"45","author":"Navarathinam SD","year":"2023","unstructured":"Navarathinam SD, Neoh HM, Tan TL, Wahab AA, Mohd Nizam Tzar MN, Ding CH. Antifungal susceptibility profile and biofilm-producing capability of Candida tropicalis isolates in a tertiary medical centre. Malays J Pathol. 2023, 45:417-24.","journal-title":"Malays J Pathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1125241","article-title":"High prevalence of fluconazole resistant Candida tropicalis among candiduria samples in China: an ignored matter of concern","volume":"14","author":"Fan X","year":"2023","unstructured":"Fan X, Tsui CK, Chen X, Wang P, Liu ZJ, Yang CX. High prevalence of fluconazole resistant Candida tropicalis among candiduria samples in China: an ignored matter of concern. Front Microbiol. 2023, 14:1125241. 10.3389\/fmicb.2023.1125241","journal-title":"Front Microbiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae264","article-title":"Molecular and epidemiological investigation of fluconazole-resistant Candida parapsilosis-Georgia, United States, 2021","volume":"11","author":"Misas E","year":"2024","unstructured":"Misas E, Witt LS, Farley MM, et al.. Molecular and epidemiological investigation of fluconazole-resistant Candida parapsilosis-Georgia, United States, 2021. Open Forum Infect Dis. 2024, 11:ofae264. 10.1093\/ofid\/ofae264","journal-title":"Open Forum Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/ffunb.2022.1010782","article-title":"Fluconazole-resistant Candida parapsilosis: a new emerging threat in the fungi arena","volume":"3","author":"Escribano P","year":"2022","unstructured":"Escribano P, Guinea J. Fluconazole-resistant Candida parapsilosis: a new emerging threat in the fungi arena. Front Fungal Biol. 2022, 3:1010782. 10.3389\/ffunb.2022.1010782","journal-title":"Front Fungal Biol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01001-20","article-title":"First report of candidemia clonal outbreak caused by emerging fluconazole-resistant Candida parapsilosis isolates harboring Y132F and\/or Y132F+K143R in Turkey","volume":"64","author":"Arastehfar A","year":"2020","unstructured":"Arastehfar A, Daneshnia F, Hilmio\u011flu-Polat S, et al.. First report of candidemia clonal outbreak caused by emerging fluconazole-resistant Candida parapsilosis isolates harboring Y132F and\/or Y132F+K143R in Turkey. Antimicrob Agents Chemother. 2020, 64:10.1128\/AAC.01001-20","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2022.05.004","article-title":"Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression","volume":"29","author":"Castanheira M","year":"2022","unstructured":"Castanheira M, Deshpande LM, Davis AP, Carvalhaes CG, Pfaller MA. Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression. J Glob Antimicrob Resist. 2022, 29:371-7. 10.1016\/j.jgar.2022.05.004","journal-title":"J Glob Antimicrob Resist"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2020.01.004","article-title":"Candida auris candidaemia in an intensive care unit - Prospective observational study to evaluate epidemiology, risk factors, and outcome","volume":"57","author":"Shastri PS","year":"2020","unstructured":"Shastri PS, Shankarnarayan SA, Oberoi J, Rudramurthy SM, Wattal C, Chakrabarti A. Candida auris candidaemia in an intensive care unit - Prospective observational study to evaluate epidemiology, risk factors, and outcome. J Crit Care. 2020, 57:42-8. 10.1016\/j.jcrc.2020.01.004","journal-title":"J Crit Care"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz262","article-title":"Development of high-level echinocandin resistance in a patient with recurrent Candida auris candidemia secondary to chronic candiduria","volume":"6","author":"Biagi MJ","year":"2019","unstructured":"Biagi MJ, Wiederhold NP, Gibas C, Wickes BL, Lozano V, Bleasdale SC, Danziger L. Development of high-level echinocandin resistance in a patient with recurrent Candida auris candidemia secondary to chronic candiduria. Open Forum Infect Dis. 2019, 6:ofz262. 10.1093\/ofid\/ofz262","journal-title":"Open Forum Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.07.008","article-title":"First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia","volume":"73","author":"Calvo B","year":"2016","unstructured":"Calvo B, Melo AS, Perozo-Mena A, et al.. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect. 2016, 73:369-74. 10.1016\/j.jinf.2016.07.008","journal-title":"J Infect"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx045","article-title":"Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14)","volume":"72","author":"Bretagne S","year":"2017","unstructured":"Bretagne S, Renaudat C, Desnos-Ollivier M, Sitbon K, Lortholary O, Dromer F. Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14). J Antimicrob Chemother. 2017, 72:1784-93. 10.1093\/jac\/dkx045","journal-title":"J Antimicrob Chemother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/431010-epidemiology-and-antifungal-susceptibility-of-candida-bloodstream-isolates-from-a-tertiary-care-center-in-central-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:43:41Z","timestamp":1763448221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/431010-epidemiology-and-antifungal-susceptibility-of-candida-bloodstream-isolates-from-a-tertiary-care-center-in-central-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.97120","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,17]]}}}